文献速递细菌感染、耐药与抗菌药物

低收入和中等收入国家社区抗菌药物管理干预的有效性:叙述性综述

What are the most effective community-based antimicrobial stewardship interventions in low- and middle-income countries? A narrative review.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该叙述性综述评估了在低收入和中等收入国家(LMIC)实施社区抗菌药物管理干预的证据。综述发现,多方面的、以教育为重点的干预措施可能最有效,但社区干预研究的质量和数量有限,亟需微生物学、临床和经济可持续性方面的研究。

要点

  • 多方面的、以教育为重点的干预措施可能最有效。
  • 社区抗菌药物管理干预研究质量和数量有限。
  • 亟需微生物学、临床和经济可持续性研究。

核心结论

  • 多方面的、以教育为重点的干预措施在LMIC社区可能最有效。
  • 社区抗菌药物管理干预研究的质量和数量有限。

研究设计与样本

  • 叙述性综述,检索并批判性评估LMIC社区抗菌药物管理干预的证据。

主要发现

  • 多方面的、以教育为重点的干预措施可能最有效。
  • 社区干预研究的质量和数量有限。
  • 亟需微生物学、临床和经济可持续性研究。

临床怎么用

  • 在LMIC社区可优先考虑多方面的教育干预策略。

局限性

  • 社区抗菌药物管理干预研究的质量和数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial resistance (AMR) is a major global issue and antimicrobial stewardship is central to tackling its emergence. The burden of AMR disproportionately impacts low- and middle-income countries (LMICs), where capacity for surveillance and management of resistant pathogens is least developed. Poorly regulated antibiotic consumption in the community is a major driver of AMR, especially in LMICs, yet community-based interventions are neglected in stewardship research, which is often undertaken in high-income settings and/or in hospitals. We reviewed the evidence available to researchers and policymakers testing or implementing community-based antimicrobial stewardship strategies in LMICs. We critically appraise that evidence, deliver recommendations and identify outstanding areas of research need. We find that multifaceted, education-focused interventions are likely most effective in our setting. We also confirm that the quality and quantity of community-based stewardship intervention research is limited, with research on microbiological, clinical and economic sustainability most urgently needed.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Lam TT, Dang DA, Tran HH, et al. What are the most effective community-based antimicrobial stewardship interventions in low- and middle-income countries? A narrative review. J Antimicrob Chemother. 2021. PMID: 33491090. doi:10.1093/jac/dkaa556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。